Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Günter Auerswald

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Thrombosis Research|November 22, 2013
Inhibitors and prophylaxis in paediatric haemophilia patients: focus on the German experienceKarin Kurnik, Günter Auerswald, Wolfhart Kreuz
Haematologica|June 27, 2003
The role of plasma-derived factor VIII/von Willebrand factor concentrates in the treatment of hemophilia A patientsGünter Auerswald, Torsten Spranger, Hans-Hermann Brackmann
Critical Reviews in Oncology/Hematology|October 4, 2011
The case for wider use of recombinant factor VIII concentratesCedric Hermans, Hans-Hermann Brackmann, Piercarla Schinco, et al.
Thrombosis and Haemostasis|January 25, 2024
A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand DiseaseLucia Rugeri, Will Thomas, Kathrin Schirner, et al.
Thrombosis Research|December 24, 2013
Prospective study of continuous infusion with Beriate® P in patients with severe haemophilia A undergoing surgery - a subgroup analysisGünter Auerswald, Andrea Bade, Julia Johne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 16, 2020
Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panelCarmen Escuriola-Ettingshausen, Günter Auerswald, Christoph Königs, et al.
Therapeutic Advances in Hematology|March 16, 2026
An analysis of attitudes toward gene therapy in people with severe hemophilia in Germany, a survey-based cross-sectional studySvetlana Babayeva, Aida Peyvandi, Christian Schepperle, et al.
European Journal of Haematology|January 21, 2012
Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practiceGary Benson, Günter Auerswald, Ivo Elezović, et al.
Blood Transfusion = Trasfusione Del Sangue|January 13, 2018
Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical managementGary Benson, Günter Auerswald, Gerry Dolan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 21, 2016
Pain and pain management in haemophiliaGünter Auerswald, Gerry Dolan, Anne Duffy, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Thrombosis Research|November 22, 2013
Inhibitors and prophylaxis in paediatric haemophilia patients: focus on the German experienceKarin Kurnik, Günter Auerswald, Wolfhart Kreuz
Haematologica|June 27, 2003
The role of plasma-derived factor VIII/von Willebrand factor concentrates in the treatment of hemophilia A patientsGünter Auerswald, Torsten Spranger, Hans-Hermann Brackmann
Critical Reviews in Oncology/Hematology|October 4, 2011
The case for wider use of recombinant factor VIII concentratesCedric Hermans, Hans-Hermann Brackmann, Piercarla Schinco, et al.
Thrombosis and Haemostasis|January 25, 2024
A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand DiseaseLucia Rugeri, Will Thomas, Kathrin Schirner, et al.
Thrombosis Research|December 24, 2013
Prospective study of continuous infusion with Beriate® P in patients with severe haemophilia A undergoing surgery - a subgroup analysisGünter Auerswald, Andrea Bade, Julia Johne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 16, 2020
Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panelCarmen Escuriola-Ettingshausen, Günter Auerswald, Christoph Königs, et al.
Therapeutic Advances in Hematology|March 16, 2026
An analysis of attitudes toward gene therapy in people with severe hemophilia in Germany, a survey-based cross-sectional studySvetlana Babayeva, Aida Peyvandi, Christian Schepperle, et al.
European Journal of Haematology|January 21, 2012
Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practiceGary Benson, Günter Auerswald, Ivo Elezović, et al.
Blood Transfusion = Trasfusione Del Sangue|January 13, 2018
Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical managementGary Benson, Günter Auerswald, Gerry Dolan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 21, 2016
Pain and pain management in haemophiliaGünter Auerswald, Gerry Dolan, Anne Duffy, et al.
Pageof 3